Synthetic fibronectin fragments as inhibitors of retroviral infe

Details Synthetic fibronectin fragments as inhibitors of retroviral infe Synthetic fibronectin fragments as inhibitors of retroviral infe

1994-08-16

1996-08-13

Kim, Kay K. A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, 514 14, 514 15, 514 16, 514 8, 514 21, 530325, 530324, 530326, 530327, 530328, 530345, 530404, 530408, 530405, 530409, 530367, 435236, A61K 3839, A61K 3808, A61K 3810, C07K 1702

Patent

active

055456200

ABSTRACT:
The invention includes methods for inhibiting retroviral infections such as HIV. The methods of this invention involve the use of certain fragments of fibronectin and such fragments conjugated to carrier molecules such as ovalbumin to inhibit retroviral infections. The invention also includes novel proteins which comprise fibronectin fragments covalently linked to carrier proteins.

REFERENCES:
patent: 4703108 (1987-10-01), Silver et al.
patent: 5019646 (1991-05-01), Furcht et al.
patent: 5147797 (1992-09-01), McCarthy et al.
Fauci (1993) Science 262 : 1011-1018.
Cohen (1993) Science 262 : 980-981.
"Clinical Pharmacology" pp. 2596-2649 of The Merck Manual of Diagnosis and Therapy 16th edition (1992).
Danilov et al. (1989) Experimental Cell Res 182 : 186-196.
Haugen et al. (1992) J. Neurosci. 12 (6): 2034-2042.
Wilke et al. (1991) J. Invest. Dermatol. 97 (3): 573-579.
Haugen et al. (1990) J. Cell Biol. 111(6, pt. 1): 2733-45.
McCarthy et al. (1990) J. Cell Biol. 110 (3): 777-787.
McCarthy et al (1988) Biochemistry 27(4): 1380-88.
Su et al (1991) Mol. Immunol. 28 (8): 811-817.
Weeks et al. (1991) J. Cell. Biol. 114(4) : 847-53.
Taylor et al. (1992) Proc. Natl. Head Sci USA 89(20) : 9617-9621.
Kul'berg (1990) AIDS Res. Hum. Retroviruses 6(9): 1059-350115 60.
Oswald et al. (1991) FEBS Lett. 292 (1-2): 298-300.
Furcht, L T, 1983, Structure and Function of the adhesive Glycoprotein Fibronectin Mod. Cell Biol. 53-117.
Finberg, R W et al., 1991, Selective elimination of HIV-1 infected cells using an IL-2 receptor specific cytotoxin. Science 252 : 1703-1705.
Fischl, M A et al., 1987, The efficacy of AZT in the treatment of patients with AIDS and AIDS-related compex, New England J. Med. 317 : 185-191.
Hildreth, J. E. K. et al., 1989, Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244 : 1075-1078.
Kalter, D. C. et al., 1991, Inhibition of human Immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol. Lett. 30 : 219-227.
Pantaleo, G. et al., 1991, HIV infection in CD4+ T-Lymphocytes genetically deficient in LFA-1; HIV-1 is required for HIV-mediated cell fusion but not for viral transmission. J. Exp. Med. 173 : 511-514.
Pluda, J M et al., 1990, Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor uses as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection, Blood 76 : 463-472.
Rosenberg, Z F et al., 1991, Immunopathogenesis of HIV infection. FASEB J. 5 : 2382-2390.
Szebeni, J. et al., 1990, Dipyridamole potentates the activity of zidovudine and other dideoxynucleosides against HIV-1 in cultured cells. Annals N.Y. Acad. Sci. 626 : 613-616.
Szebeni, J. et al., 1990, Inhibition of HIV-1 in monocyte/macrophage cultures by 2', 3'-dideoxycytidine-5'-triphosphate, free and in liposomes. AIDS Research and Human Retroviruses 6 : 691-702.
Wahl, S M et al., 1991, Macrophage- and Astrocyte-derived Transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrom. J. Exp. Med. 173 : 981-991.
Weinstein; J N et al., 1991, Synergistic drug combinations in AIDS therapy. Annals. N.Y. Acad. Sci. 616 : 367-384.
Albeda, S M et al., 1990, Integrins and other cell adhesion molecules. FASEB J. 4 : 2868-2880.
Ruoslahti, E. 1991, Integrins. J. Clin. Invest. 87 : 1-5.
Springer; T. 1990, Adhesion receptors of the immune system. Nature 346: 425-434.
Verfaile, C M et al., 1991, Differentiation of primitive human multipotent hematopoietic progenitors into single-lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J. Exp. Med. 174 : 693-703.
Wahl, L M et al., 1984, Isolation of human mononuclear cell subsets by counterflow centrifugal elution. Cell. Immunol. 85 : 373-383.

Affiliated with

Also associated with

Rating

Synthetic fibronectin fragments as inhibitors of retroviral infe does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic fibronectin fragments as inhibitors of retroviral infe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic fibronectin fragments as inhibitors of retroviral infe will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1047952